BIOMX INC.

Profile

Company Names

BIOMX INC.

Addresses

22 EINSTEIN STREET, FLOOR 4, NESS ZIONA, L3 7414003

22 EINSTEIN ST., FLOOR 4, NESS ZIONA, L3 7414003

22 EINSTEIN ST., FLOOR 5, NESS ZIONA, L3 7414003

Phone Numbers

+972 723942377
(+972) 723942377

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$72,308,763.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2026-01-13 
$3,300,000.00 
$3,300,000.00 
$0.00 
Equity 
4
2024-03-15 
$61,547,439.00 
$61,547,439.00 
$0.00 
Equity 
3
2023-02-27 
$1,461,324.00 
$7,484,390.00 
$6,023,066.00 
Equity 
2
2021-12-21 
$3,000,000.00 
$4,998,293.00 
$1,998,293.00 
Equity 
1
2021-10-14 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GBOLA 
 
AMUSA 
DIRECTOR
BIOMX INC.
MERAV 
 
BASSAN 
EXECUTIVE OFFICER
BIOMX INC.
SUSAN 
 
BLUM 
DIRECTOR
BIOMX INC.
AVI 
 
GABAY 
EXECUTIVE OFFICER
BIOMX INC.
JESSE 
 
GOODMAN 
DIRECTOR
ADAPTIVE PHAGE THERAPEUTICS, INC.   |  BIOMX INC.
RUSSELL 
 
GREIG 
DIRECTOR
TIGENIX NV   |  MERUS N.V.   |  BIOMX INC.
JONAS 
 
GROSSMAN 
DIRECTOR
CHINA BROADBAND INC   |  BIOMX INC.   |  ZOOZ POWER LTD.
JONATHAN 
 
LEFF 
DIRECTOR
HANA BIOSCIENCES INC   |  RIB X PHARMACEUTICALS INC   |  TALON THERAPEUTICS, INC.   |  N30 PHARMACEUTICALS, INC.   |  AUDENTES THERAPEUTICS, INC.   |  AVEXIS, INC.   |  APRECIA PHARMACEUTICALS CO   |  PROTEON THERAPEUTICS INC   |  DRACEN PHARMACEUTICALS, INC.   |  ARS PHARMACEUTICALS, INC.   |  MIRUM PHARMACEUTICALS, INC.   |  CHONDRIAL THERAPEUTICS HOLDINGS, LLC   |  LARIMAR THERAPEUTICS, INC.   |  AVALYN PHARMA INC.   |  AEROVATE THERAPEUTICS, INC.   |  ADAPTIVE PHAGE THERAPEUTICS, INC.   |  INNERVACE, INC.   |  BIOMX INC.   |  ELION THERAPEUTICS, INC.   |  AXONIS THERAPEUTICS, INC.
GREGORY 
 
MERRIL 
DIRECTOR
ADAPTIVE PHAGE THERAPEUTICS, INC.   |  BIOMX INC.
ALAN 
 
MOSES 
DIRECTOR
BIOMX INC.
ASSAF 
 
ORON 
EXECUTIVE OFFICER
BIOMX INC.
SAILAJA 
 
PUTTAGUNTA 
EXECUTIVE OFFICER
BIOMX INC.
PAUL 
 
SEKHRI 
DIRECTOR
ARYX THERAPEUTICS, INC.   |  MACROGENICS INC   |  PATIENTSAFE SOLUTIONS, INC.   |  TANDEM DIABETES CARE INC   |  LYCERA CORP   |  PETRA PHARMA CORP   |  LIKEMINDS, INC./DE   |  COMPUGEN LTD   |  ALPINE IMMUNE SCIENCES, INC.   |  EGENESIS, INC.   |  ADITUM BIO FUND 1, L.P.   |  BIOMX INC.   |  AXCELLA HEALTH INC.
JONATHAN 
 
SOLOMON 
EXECUTIVE OFFICER, DIRECTOR
GREENLEASE PORTFOLIO II, L.P.   |  NEUROPHAGE PHARMACEUTICALS INC   |  RED LEAF CHICAGO, LLC   |  BIOMX INC.   |  NPHUB INC.
JONATHAN 
EITAN 
SOLOMON 
EXECUTIVE OFFICER, DIRECTOR
BIOMX INC.
LYNNE 
 
SULLIVAN 
DIRECTOR
SOLID BIOSCIENCES INC.   |  INOZYME PHARMA, INC.   |  BIOMX INC.
EDDIE 
 
WILLIAMS 
DIRECTOR
BIOMX INC.
EDWARD 
 
WILLIAMS 
DIRECTOR
NOVINDA CORP.   |  BUZZ-WORTHY PROPERTIES I, LLC   |  BONUMOSE, INC.   |  BIOMX INC.
MARINA 
 
WOLFSON 
EXECUTIVE OFFICER
BIOMX INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-01-20
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2026-01-13 
2024-04-01
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2024-03-15 
2023-03-03
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2023-02-27 
2022-01-04
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2021-12-21 
2021-10-25
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2021-10-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
000000375
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
119037
NONE
NONE
RBC CAPITAL MARKETS, LLC
31194
NONE
NONE
NONE
NONE